THCC
THCC at a glance
Naturally occurring
Psychoactive
Cannabinoid type
Discovery year
Also known as
Molecular formula
C17H22O2
CB1 receptor interaction
CB2 receptor interaction
What is THCC?
THCC (tetrahydrocannabiorcol) is a rare, naturally occurring phytocannabinoid and the shortest side-chain member of the THC family. It is considered non-intoxicating and is the one-carbon homologue of Delta-9-THC. THCC has been detected in cannabis, hashish and pollen from male Cannabis sativa plants, but only in very small amounts.
THCC has the same basic THC structure as Delta-9-THC, but contains a one-carbon (methyl) side chain instead of the five-carbon (pentyl) side chain of Delta-9-THC. This shorter side chain strongly reduces its cannabinoid activity and makes THCC an important comparison point for understanding how side-chain length influences THC homologues.
Because natural concentrations are extremely low, THCC is generally produced synthetically for research and analytical use rather than extracted commercially from cannabis. It is mainly available as purified analytical material. Detailed information about its appearance, crystallisation behaviour, storage stability and degradation products remains limited.
THCC was first identified in cannabis in 1972. Research has remained very limited, with no human clinical studies available. Its main scientific relevance comes from its unusually short side chain, which helps researchers study how structural differences across the THC homologue series affect biological activity.
How THCC works in the human body
THCC appears to produce its biological effects mainly through TRP ion channels rather than meaningful activation of CB1 or CB2 receptors. The strongest evidence involves TRPA1, which has been directly linked to pain-reducing effects in animals. THCC also activates TRPV1 and TRPV2, while laboratory research suggests possible protective effects on nerve cells.
CB1 receptor
The main cannabinoid receptor in the brain, responsible for THC’s intoxicating effects. THCC does not appear to meaningfully activate CB1. Experimental research has reported no detectable CB1 agonist activity, which is consistent with THCC being considered non-intoxicating. However, its psychoactive effects have not been directly studied in humans.
CB2 receptor
The main cannabinoid receptor in the immune system, involved in regulating immune cell activity and inflammatory responses. THCC also shows no detectable agonist activity at CB2 in available experimental research. It therefore currently appears unlikely that direct CB2 activation is an important mechanism behind THCC’s effects.
TRP ion channels
TRP channels are involved in sensory signalling, including pain and temperature responses. THCC activates TRPA1, with reported EC50 values of approximately 10 to 30 µM across human, mouse and rat receptors. Animal research found that THCC reduced pain responses through TRPA1, providing direct evidence for this mechanism.
THCC also activates TRPV1 and TRPV2. These channels may contribute to sensory, pain and inflammatory signalling, although their importance to THCC’s effects has not yet been established in humans.
Neuroprotective cell effects
Laboratory research suggests that THCC may help protect nerve cells under stressful conditions. THCC reduced cell damage and increased levels of a protein involved in nerve-cell survival and function. No toxicity was detected in the tested cells at concentrations up to 50 µM. These effects have only been demonstrated in laboratory cell models and have not been confirmed in animals or humans.
Metabolism
The metabolism of THCC has not been well characterised. There are currently no established human pharmacokinetic data or confirmed active human metabolites. A likely primary metabolite would be 11-OH-THCC, but this has not been confirmed in humans.
Human safety status
No direct human data, considered likely safe based on similar cannabinoids
No controlled human trials, human pharmacokinetic studies or dedicated human toxicology studies have established the safety of THCC.
Some preclinical information is available. THCC has been studied in animals for its effects on pain signalling, while laboratory research found no detectable toxicity in nerve-cell models at concentrations up to 50 µM. These findings are not sufficient to establish safe human doses, long-term safety or possible drug interactions.
THCC interactions with other compounds
Important disclaimer
This information is provided for educational and technical reference only. Interaction data can change as new research becomes available and may be incomplete or outdated. The real relevance of any interaction depends strongly on dose, route of administration, timing, formulation and individual metabolism. Readers should do their own research and consult a qualified healthcare professional before making decisions involving medicines, alcohol, nicotine, cannabinoids or other compounds. Elementra's products and information are intended for research, production and technical use only and are not intended for human consumption.
Medicines
Capsaicin
Cell study
Capsaicin-induced nerve signalling decreases
THCC directly reduced the response of sensory neurons to capsaicin in laboratory testing. When THCC was applied five minutes before capsaicin, capsaicin-induced calcium influx was completely blocked in about 65% of responsive neurons, while many remaining neurons showed reduced responses. The researchers suggest that desensitization between overlapping TRPA1 and TRPV1 pain-signalling pathways may contribute, but the exact mechanism and relevance in humans remain unconfirmed.
This content does not constitute advice
All information in the Cannabinoid Knowledge Hub is provided solely for educational and scientific purposes. It does not constitute medical advice, usage advice, dosage guidance or instructions for mixing, combining or consuming substances.
Discussions of effects, interactions and risks are descriptive only and should not be interpreted as a recommendation or encouragement to use or combine any substance. Visitors are responsible for complying with all applicable laws and regulations in their country or jurisdiction. Nothing in the Knowledge Hub may be used to support illegal activity.
Read the full disclaimer